Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)SUCHESTON, Lara E; HUA ZHAO; CIUPAK, Gregory L et al.Breast cancer research and treatment. 2011, Vol 130, Num 3, pp 993-1002, issn 0167-6806, 10 p.Article

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous BisphosphonatesFIZAZI, Karim; LIPTON, Allan; MARIETTE, Xavier et al.Journal of clinical oncology. 2009, Vol 27, Num 10, pp 1564-1571, issn 0732-183X, 8 p.Article

Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography : Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast CancerDUNNWALD, Lisa K; GRALOW, Julie R; SCHUBERT, Erin K et al.Journal of clinical oncology. 2008, Vol 26, Num 27, pp 4449-4457, issn 0732-183X, 9 p.Article

Preoperative Therapy in Invasive Breast Cancer : Pathologic Assessment and Systemic Therapy Issues in Operable DiseaseGRALOW, Julie R; BURSTEIN, Harold J; WINER, Eric P et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 814-819, issn 0732-183X, 6 p.Article

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer : Southwest oncology group/intergroup study 9623MOORE, Halle C. F; GREEN, Stephanie J; ELIAS, Anthony D et al.Journal of clinical oncology. 2007, Vol 25, Num 13, pp 1677-1682, issn 0732-183X, 6 p.Article

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapyMANKOFF, David A; DUNNWALD, Lisa K; GRALOW, Julie R et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 11, pp 1806-1814, issn 0161-5505, 9 p.Article

Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancerBELLON, Jennifer R; LINDSLEY, Karen L; ELLIS, Georgiana K et al.International journal of radiation oncology, biology, physics. 2000, Vol 48, Num 2, pp 393-397, issn 0360-3016Conference Paper

Assessing the Discordance Rate Between Local and Central HER2 Testing in Women With Locally Determined HER2-Negative Breast CancerKAUFMAN, Peter A; BLOOM, Kenneth J; LALLA, Deepa et al.Cancer. 2014, Vol 120, Num 17, pp 2657-2664, issn 0008-543X, 8 p.Article

Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA TrialGOODWIN, Pamela J; SEGAL, Roanne J; LEVINE, Mark et al.Journal of clinical oncology. 2014, Vol 32, Num 21, pp 2231-2239, issn 0732-183X, 9 p.Article

Frequent Antibiotic Use and Second Breast Cancer EventsWIRTZ, Heidi S; BUIST, Diana S. M; GRALOW, Julie R et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 9, pp 1588-1599, issn 1055-9965, 12 p.Article

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the North Central Cancer Treatment Group N9831 TrialPEREZ, Edith A; DUECK, Amylou C; KUTTEH, Leila A et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2115-2122, issn 0732-183X, 8 p.Article

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer TrialPEREZ, Edith A; SUMAN, Vera J; WINER, Eric P et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1231-1238, issn 0732-183X, 8 p.Article

Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 TrialSCHNEIDER, Bryan P; GRAY, Robert J; COBLEIGH, Melody A et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1281-1289, issn 1078-0432, 9 p.Article

Supplement use during an intergroup clinical trial for breast cancer (S0221)ZIRPOLI, Gary R; BRENNAN, Patrick M; STEWART, James et al.Breast cancer research and treatment. 2013, Vol 137, Num 3, pp 903-913, issn 0167-6806, 11 p.Article

Combination Anastrozole and Fulvestrant in Metastatic Breast CancerMEHTA, Rita S; BARLOW, William E; HORTOBAGYI, Gabriel N et al.The New England journal of medicine. 2012, Vol 367, Num 5, pp 435-444, issn 0028-4793, 10 p.Article

Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast CancerLINDEN, Hannah M; KURLAND, Brenda F; LINK, Jeanne M et al.Clinical cancer research (Print). 2011, Vol 17, Num 14, pp 4799-4805, issn 1078-0432, 7 p.Article

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose UptakeDUNNWALD, Lisa K; DOOT, Robert K; MUZI, Mark et al.Clinical cancer research (Print). 2011, Vol 17, Num 8, pp 2400-2409, issn 1078-0432, 10 p.Article

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast CancerPEREZ, Edith A; SUMAN, Vera J; MORENO-ASPITIA, Alvaro et al.Journal of clinical oncology. 2011, Vol 29, Num 34, pp 4491-4497, issn 0732-183X, 7 p.Article

Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast CancerSPECHT, Jennifer M; KURLAND, Brenda F; SCHUBERT, Erin K et al.Clinical cancer research (Print). 2010, Vol 16, Num 10, pp 2803-2810, issn 1078-0432, 8 p.Article

Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerMUSS, Hyman B; BERRY, Donald A; KARTCHESKE, Patricia A et al.The New England journal of medicine. 2009, Vol 360, Num 20, pp 2055-2065, issn 0028-4793, 11 p.Article

Serial 2-[¹⁸F] fluoro -2 -deoxy -D -glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)SPECHT, Jennifer M; TAM, Stephen L; KURLAND, Brenda F et al.Breast cancer research and treatment. 2007, Vol 105, Num 1, pp 87-94, issn 0167-6806, 8 p.Article

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancerLINDEN, Hannah M; STEKHOVA, Svetlana A; KROHN, Kenneth A et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2793-2799, issn 0732-183X, 7 p.Article

Blood flow and metabolism in locally advanced breast cancer: Relationship to response to therapyMANKOFF, David A; DUNNWALD, Lisa K; GRALOW, Julie R et al.The Journal of nuclear medicine (1978). 2002, Vol 43, Num 4, pp 500-509, issn 0161-5505Article

Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinomaDALING, Janet R; MALONE, Kathleen E; DOODY, David R et al.Cancer. 2001, Vol 92, Num 4, pp 720-729, issn 0008-543XArticle

[¹⁸F]fluoroestradiol radiation dosimetry in human PET studiesMANKOFF, David A; PETERSON, Lanell M; TEWSON, Timothy J et al.The Journal of nuclear medicine (1978). 2001, Vol 42, Num 4, pp 679-684, issn 0161-5505Article